Quest Diagnostics Incorporated

NYSE:DGX

Market Cap

USD 18.80 B

Share Price

USD 168.37

Avg Daily Volume

1,146,698

Change (1 day)

0.17%

Change (1 year)

16.83%

Change (YTD)

11.61%

Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 14.13%

Quest Diagnostics Incorporated EBIT Margin is 14.13% for the Trailing 12 Months (TTM) ending March 31, 2025, a 1.39% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 13.93%, a 10.95% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.56%, a -47.94% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 24.12%, a -2.39% change year over year.
  • Quest Diagnostics Incorporated EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 24.71%, a 63.40% change year over year.
Key Data
Date EBIT Margin EBITDA Margin Net Income Margin EBT Margin